These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20525323)

  • 1. Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease.
    Goldsmith KA; Dyer MT; Buxton MJ; Sharples LD
    Health Qual Life Outcomes; 2010 Jun; 8():54. PubMed ID: 20525323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions.
    Goldsmith KA; Dyer MT; Schofield PM; Buxton MJ; Sharples LD
    Health Qual Life Outcomes; 2009 Nov; 7():96. PubMed ID: 19941657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework.
    Wijeysundera HC; Tomlinson G; Norris CM; Ghali WA; Ko DT; Krahn MD
    Med Decis Making; 2011; 31(3):481-93. PubMed ID: 21127316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
    Moore A; Young CA; Hughes DA
    Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
    PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.
    Kim HL; Kim D; Jang EJ; Lee MY; Song HJ; Park SY; Cho SK; Sung YK; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim SK; Kim TH; Kim TJ; Koh E; Lee H; Lee HS; Lee J; Lee SS; Lee SW; Park SH; Shim SC; Yoo DH; Yoon BY; Bae SC; Lee EK
    Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease.
    Li C; Dou L; Fu Q; Li S
    Health Qual Life Outcomes; 2023 Jul; 21(1):64. PubMed ID: 37400827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
    Yang Q; Yu XX; Zhang W; Li H
    Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.
    Dakin H; Gray A; Murray D
    Qual Life Res; 2013 Apr; 22(3):683-94. PubMed ID: 22555470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping a patient-reported functional outcome measure to a utility measure for comparative effectiveness and economic evaluations in older adults with low back pain.
    Rundell SD; Bresnahan BW; Heagerty PJ; Comstock BA; Friedly JL; Jarvik JG; Sullivan SD
    Med Decis Making; 2014 Oct; 34(7):873-83. PubMed ID: 24829274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP.
    Peak J; Goranitis I; Day E; Copello A; Freemantle N; Frew E
    Health Qual Life Outcomes; 2018 May; 16(1):106. PubMed ID: 29843726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping EQ-5D utility scores from the PedsQL™ generic core scales.
    Khan KA; Petrou S; Rivero-Arias O; Walters SJ; Boyle SE
    Pharmacoeconomics; 2014 Jul; 32(7):693-706. PubMed ID: 24715604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities.
    Gu NY; Botteman MF; Ji X; Bell CF; Carter JA; van Hout B
    Health Qual Life Outcomes; 2011 Dec; 9():119. PubMed ID: 22208861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the Beck Depression Inventory to the EQ-5D-3L in Patients with Depressive Disorders.
    Grochtdreis T; Brettschneider C; Hajek A; Schierz K; Hoyer J; Koenig HH
    J Ment Health Policy Econ; 2016 Jun; 19(2):79-89. PubMed ID: 27453455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a transformation model to derive general population-based utility: Mapping the pruritus-visual analog scale (VAS) to the EQ-5D utility.
    Park SY; Park EJ; Suh HS; Ha D; Lee EK
    J Eval Clin Pract; 2017 Aug; 23(4):755-761. PubMed ID: 28194852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).
    Badia X; Roset M; Valassi E; Franz H; Forsythe A; Webb SM
    Qual Life Res; 2013 Dec; 22(10):2941-50. PubMed ID: 23539468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.